ZENLABS ETHICA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.98 INR | +0.74% |
|
-8.83% | -1.01% |
Zenlabs Ethica Limited is an India-based marketing company. The Company is engaged in trading in a range of branded drugs, including gastrointestinal tract disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps and anti-bacterial drugs, nutraceuticals, and other. It has approximately five manufacturing units. It operates through three divisions: Zenlabs, Coles Pharma and Mega Star. Zenlabs division provides various products, including Analgesics & Anti-Inflammatory, Skin Preparations, Neurological Disorders, Eye, Ear and Nasal Drops, Anti-Diabetic, Anti-Depressant, Anti-Infective, Anti-Emetic, Steroid & Anabolic Steroid, Anti-Hypertensive Drugs, Anti Allergic, Anti Cold & Cough Syrup, Nutraceuticals, Antacid, Enzymes & Appetite Stimulant, Ayurvedic Preparation, GIT Disorders, Soap, and Other Pharmaceutical Drugs. Coles Pharma division provides various products, including Analgesics & Anti-Inflammatory, Nutraceuticals, Skin Preparations, and other.
Sector
Pharmaceuticals
Calendar
18/07/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -1.01% | 3.2M | |
| -1.52% | 24.18B | |
| +3.67% | 8.46B | |
| +8.55% | 8.34B | |
| -23.71% | 7.64B | |
| +15.20% | 5.33B | |
| +2.68% | 4.12B | |
| -6.90% | 3.92B | |
| +5.56% | 3.89B | |
| +18.80% | 3.54B |
- Stock Market
- Equities
- ZENLABS6 Stock
- News Zenlabs Ethica Limited
- Zenlabs Ethica Appoints CFO
